An experimental, aspirational growth strategy — ES/MES futures with disciplined risk scaling and yearly compounding.
This is a theoretical framework based on edge metrics observed in past testing. The growth targets are mathematically derived from historical trade data but have not yet been proven over a full annual cycle. Treat all projections as aspirational goals, not guaranteed outcomes.
Starting Capital
$10,000
Daily Risk
$1,000
3-Year Goal
$100K
Last Updated: — | 0 trades (All-Time)
This is an experimental and aspirational project. Growth targets are theoretically possible based on edge metrics from past testing but have not been proven over a full cycle. All projections are mathematical extrapolations from a $10,000 starting portfolio — not guarantees. Past performance is not indicative of future results. Not investment advice.
$10,000 → $100,000 in 3 years through yearly compounding at ~115% CAGR
The rule: Q0 is a trial quarter — trade at base risk ($1,000/day) to validate the edge before committing to the scaling plan. Once edge is confirmed, compound ~115% annually. At each year-end, scale risk proportionally to the new account size (always 10%). Same edge, larger position sizes → $10K becomes $100K in 3 years.
$10,000 × (1 + 1.154)³ = $100,000
Required CAGR: ~115% · Compounding frequency: Yearly · Horizon: 3 years
| Phase | Starting Balance | Risk/Day (10%) | Annual Return | End Balance | Action |
|---|---|---|---|---|---|
| Q0 TRIAL | $10,000 | $1,000 | Validate edge | $10,000+ | Edge confirmed → begin compounding |
| Year 1 | $10,000 | $1,000 | +$11,544 (+115%) | $21,544 | Scale risk to 10% of new balance |
| Year 2 | $21,544 | $2,154 | +$24,872 (+115%) | $46,416 | Scale risk to 10% of new balance |
| Year 3 | $46,416 | $4,642 | +$53,584 (+115%) | $100,000 | Goal reached |
Year 1: $10K → $21.5K
+115% at $1K/day risk
Year 2: $21.5K → $46.4K
+115% at $2.2K/day risk
Year 3: $46.4K → $100K
+115% at $4.6K/day risk
Important context: The ~115% annual CAGR is derived from edge metrics observed in past testing. Risk scales conservatively once per year (always 10% of the year-start balance), not intra-year. Q0 exists specifically to validate the edge in live conditions before any compounding begins. This has not been proven over a multi-year cycle. Real-world execution will face drawdowns, slippage, and market regime changes. The yearly compounding approach is deliberately more conservative than quarterly scaling — but sustained ~115% annual returns remain the unproven variable.
Real Tradovate fills from the Ekantik Accelerator execution — every trade, win or loss
Data Transparency: All trades are real Tradovate fills.
NET P&L
—
0 trades
RETURN
—
on $10,000
EV / TRADE
—
$/trade
WIN RATE
—
0W / 0L
PROFIT FACTOR
—
gross W / L
MAX DRAWDOWN
—
0%
NET MES PTS
—
avg W/L pts
Portfolio
$10,000
Starting capital
Daily Risk
$1,000
10% of portfolio
Instrument
ES/MES
S&P 500 Futures
Contract
1
$5/point MES
Upload trade data to see monthly breakdown
Upload trade data to see equity curve
S&P 500
—
Ekantik Accelerator
—
vs S&P 500
—
Est. Max DD
—
Upload trade data to see inception summary
EDGE PER TRADE
—
—
AVG WIN
—
—
AVG LOSS
—
—
WIN RATE
—
Upload trade data to see edge analysis
—
—
—
—
—
| Strategy | Edge/Trade | Trades/Mo | Annual R | Kelly % |
|---|
WHY MAGNITUDE MATTERS
—
WHY FREQUENCY MATTERS
—
| Date/Time | Trade# | B/S | Entry | Stop | Qty | Net Pts | Risk(Pts) | Net$ | Result |
|---|
Past performance is not indicative of future results. Trading futures involves substantial risk of loss. This dashboard displays real execution data for transparency and educational purposes only. Nothing herein constitutes investment advice.